Intellectual Property

Section 101 of the U.S. Patent Act─which identifies four categories of inventions or discoveries that are eligible for patent protection─presents a number of challenges to companies working on innovations in the life sciences space. Jones Day’s Patricia Campbell and Susan Gerber, who recently coauthored an article on this topic for The Intellectual Property Strategist, are joined by Meredith Wilkes in this edition of Jones Day Talks Intellectual Property. They discuss Section 101 and life sciences, and talk about what’s coming up for Jones Day’s Women in IP initiative.

Read the full transcript on the Jones Day website.

In its April 2018 decision in SAS Institute, Inc. v. Iancu, the U.S. Supreme Court held that when conducting an inter partes review, the U.S. Patent Office must determine the patentability of each of the claims challenged by the petitioner.

Jones Day partners Dave Cochran  and Matt Johnson explain how SAS Institute reverses prior interpretations of the inter partes review statute and discuss where it has already affected litigation strategies for petitioners and patent holders. (Running time: 24:51)

In a Supreme Court matter argued on behalf of software developer SAS Institute Inc., Jones Day successfully challenged part of how the U.S. Patent Office’s Patent Trial and Appeals Board conducts its inter partes review proceedings. But that’s just half the story. Jones Day partners Greg Castanias, Dave Cochran, and John Marlott explain why the Supreme Court’s decision has significant implications for cases involving government agency overreach. 

The “monkey selfie” matter raises intriguing questions regarding the current state of U.S. copyright laws. Courts have ruled that a non-human can’t be granted copyright protection, but then what are the implications for works created via artificial intelligence? Jones Day partners Meredith Wilkes and Emily Tait discuss the aftermath of Naruto v. Slater and explain how companies can guard and protect their creative work.